Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea
Clinical trial NCT02137629 · COMPLETED
Trial details
- NCT number
- NCT02137629
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-27
- Primary completion
- 2016-05-19
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.